Multiple myeloma patients with a long remission after autologous hematopoietic stem cell transplantation

Abstract excerpt

Autologous stem cell transplantation (autoHCT) is considered standard of care for newly diagnosed multiple myeloma (MM). Although most patients eventually progress after autoHCT, a small proportion achieve a durable response. In this retrospective study we included 1576 patients, 244 (15%) of whom were long-term responders (LTR), defined as having a progression-free survival (PFS) of ≥8 years after transplant....

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Multiple Myeloma Research and Treatments
• Share to Myeloproliferative Neoplasms: Diagnosis and Treatment
• Share to Protein Degradation and Inhibitors